Delivery Order SPE2DE24DA017-SPE2D626F07T8
- Not listed
- Arthrex Inc., a leading developer and manufacturer of minimally invasive orthopedic medical technologies, received a delivery order valued at $3,025.44 from the Defense Logistics Agency's Medical Supply Chain on September 16, 2025. This fixed-price delivery order with economic price adjustment is scheduled for completion by September 19, 2025, and will be performed at the company's headquarters in Naples, Florida. The award utilized no set-aside designation, reflecting Arthrex's strong...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $17,155.73 by the Defense Logistics Agency's Medical Supply Chain on December 9, 2025, with an ultimate completion date of December 12, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, reflecting Arthrex's established competitive position as a primary federal supplier. The award is issued under Arthrex's...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a $2,486.70 delivery order by the Defense Logistics Agency's Medical Supply Chain on September 17, 2025, with an ultimate completion date of September 22, 2025. This fixed-price delivery order with economic price adjustment authority covers calculus percutaneous standard anterior process supplies, which are specialized orthopedic surgical materials. The award carries no set-aside designation, reflecting...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $6,808.01 from the Defense Logistics Agency's Medical Supply Chain on August 26, 2025, with completion targeted for August 29, 2025. This fixed-price contract with economic price adjustment represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471,048,172.66 and running through...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $20,083.00 by the Defense Logistics Agency's Medical Supply Chain on July 15, 2025. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by July 18, 2025, and represents a task order issued under Arthrex's larger Indefinite Delivery Contract (IDC) SPE2DE24D0020 with the Defense Logistics Agency, valued at...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,101.65 to Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies and surgical instruments. This fixed-price delivery order with economic price adjustment (Contract No. 4569994423) was issued without a competitive set-aside on November 13, 2025, with an ultimate completion date of November 18, 2025. The delivery order falls under Arthrex's existing...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $133,490.93 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 24, 2025, with completion expected by September 29, 2025. This delivery order, issued without set-aside designation, represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471,048,172.66 and...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a fixed-price delivery order valued at $1,865.16 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025, with an ultimate completion date of September 12, 2025. This delivery order, identified as 4569386570 and designated for an HRVT BN 8MM GFT product, was issued without a set-aside designation, reflecting Arthrex's competitive standing in the federal...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order award valued at $18,192.47 from the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. The delivery order, classified as fixed price with economic price adjustment, is for implant system secondary fixation bioswivel components measuring 4.75x19.1 and is scheduled for completion by August 21, 2025. This award was made without a set-aside designation,...
- Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies and surgical instruments, was awarded a delivery order valued at $1,172.16 with an ultimate completion date of November 28, 2025. The contract, issued on November 24, 2025, is a fixed-price agreement with economic price adjustment provisions and carries no set-aside designation. This delivery order represents a task order executed under Arthrex's larger Indefinite Delivery Contract...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F07T8Delivery Order
The U.S. Department of Defense, through the Defense Logistics Agency's Medical Supply Chain, awarded a $12,051.63 delivery order to Arthrex Inc. on December 11, 2025, with completion scheduled for December 16, 2025. The delivery order, designated for depth development orthopedic instruments in 2.7, 3.5, and 4.0 millimeter configurations, is structured as a fixed-price contract with economic price adjustment provisions. This award was issued without a set-aside designation, reflecting Arthrex's established competitive position as a leading supplier of minimally invasive orthopedic medical technologies to federal healthcare systems. The order will be performed at Arthrex's headquarters facility in Naples, Florida. This delivery order falls under Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, a comprehensive master agreement valued at approximately $471 million and effective through September 2029. The parent contract authorizes procurement of orthopedic surgical implants, instruments, and biologics supporting Department of Veterans Affairs medical centers and Department of Defense healthcare facilities nationwide. Arthrex serves as the prime contractor on this effort with no identified subcontractors, maintaining direct responsibility for fulfilling government requirements across multiple orthopedic specialties and surgical applications supporting veteran and active-duty military patient populations.